![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 30, 27944-27949, July 27, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Expression by Adenoviral
Infection Involves Inactivation of the AP-2rep Transcriptional
Corepressor CtBP1*
,
,
From the AP-2 transcription factors execute important
functions during embryonic development and malignant transformation.
Recently, we have isolated a transcriptional repressor of
AP-2
Institute for Microbiology, University of
Regensburg Medical School, Franz-Josef-Strauss-Allee 11, D-93042 Regensburg, Germany, the § Institute of Pathology,
University Hospital RWTH Aachen, Pauwelsstrasse 30, D-52074 Aachen, Germany, and the ¶ Department of Biochemistry,
G08, University of Sydney,
Sydney, New South Wales 2006, Australia
expression, the novel Krüppel-related zinc
finger protein AP-2rep (Klf12). Here, we show that repression of
AP-2
transcription by AP-2rep is dependent on an
N-terminal PVDLS motif that interacts specifically with the corepressor
CtBP1 both in vivo and in vitro. This
interaction motif was previously identified in the C-terminal region of
the adenoviral oncoprotein E1A. Infection of both HeLa and PA-1
cells with adenovirus type 5 strongly induced AP-2
mRNA.
Consistently, E1A was necessary and sufficient to mediate up-regulation
of AP-2
. Transiently transfected wild-type E1A protein
activated an AP-2rep sensitive cis-regulatory element of the
AP-2
promoter, but E1A protein harboring a mutation in
the PVDLS motif failed to activate. In summary, we conclude that the
adenoviral oncoprotein E1A activates transcription from the endogenous
AP-2
gene, an effect that involves transcriptional
derepression of the AP-2
promoter by interaction of E1A
with the AP-2rep corepressor CtBP1.
To whom correspondence should be addressed. Tel.:
49-241-8089281; Fax: 49-241-8888439; E-mail:
Buettner@pat.rwth-aachen.de.
This article has been cited by other articles:
![]() |
M. Zhou, L. McPherson, D. Feng, A. Song, C. Dong, S.-C. Lyu, L. Zhou, X. Shi, Y.-T. Ahn, D. Wang, et al. Kruppel-Like Transcription Factor 13 Regulates T Lymphocyte Survival In Vivo J. Immunol., May 1, 2007; 178(9): 5496 - 5504. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Turner, H. Nicholas, D. Bishop, J. M. Matthews, and M. Crossley The LIM Protein FHL3 Binds Basic Kruppel-like Factor/Kruppel-like Factor 3 and Its Co-repressor C-terminal-binding Protein 2 J. Biol. Chem., April 4, 2003; 278(15): 12786 - 12795. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Poser, M. Golob, M. Weidner, R. Buettner, and A. K. Bosserhoff Down-Regulation of COOH-Terminal Binding Protein Expression in Malignant Melanomas Leads to Induction of MIA Expression Cancer Res., October 15, 2002; 62(20): 5962 - 5966. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Bieker Kruppel-like Factors: Three Fingers in Many Pies J. Biol. Chem., September 7, 2001; 276(37): 34355 - 34358. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |